… (16:16)(p13;q22), often denoted as t(8;21) and inv(16) [12]. … encompass cases with t(10;11)(p11.2;q23)/KMT2A-ABI1,
t(10… —have been subject to clinical evaluations for both AML and …

… , assessed in 2 different laboratories, were … clinical course of his symptoms and in an attempt
to reduce undue toxicity, the interdisciplinary physician team of neonatologists and pediatric …

… Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity:
a collaborative study by the International-Berlin-FrankfurtMunster AML-study group. Blood. …

… a rare disorder in acute magakaryoblastic leukemia in children. The first … CEP1/CEP15/dic
(1; 15) (p11; p11) is a rare form of these … 2q13.1) with inv (16) (p13.1; q22) is an extremely rare …

… Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological
entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group. …

… Acute myeloid leukemia (AML) is a clinically and biologically heterogeneous group of
neoplasms found in both the adult and pediatric populations. … Likewise, AML with at(8;16)(p11;p13) …

… (16:16)(p13;q22), often denoted as t(8;21) and inv(16) [8]. These … Study by the International
Berlin-Frankfurt-Münster Study … 8 in pediatric acute myeloid leukemia: A NOPHO-AML study. …

… may vary between different cooperative groups, most studies/… Finally, the t(8;16)(p11;p13)
rearrangement, fusing KAT6A to the … (t(8;21)(q22;q22); RUNX1-RUNX1T1, inv(16)(p13.1q22)/…

… the prognostic value of different clinical and biological factors. In … 1q22) or t(16;16)(p13.1;q22),
whose fusion products are … Recently, the Children Oncology Group explored the role of …

… Neonatal leukemia differs from pediatric leukemia by its clinical … There are currently
approximately 100 different KMT2A fusion … recent retrospective study of cases from 2001 to 2016, …